Amazon Fresh vs Johnson & Johnson
Side-by-side comparison of AI visibility scores, market position, and capabilities
Amazon's grocery delivery and physical store concept; Prime member same-day delivery from Amazon Fresh and Whole Foods competing with Walmart Grocery and Instacart for online grocery.
About
Amazon Fresh is Amazon's grocery delivery and in-store grocery service providing same-day and next-day grocery delivery (for Prime members) from Amazon Fresh's own grocery brand stores, Whole Foods Market, local grocery partners, and Amazon's own grocery fulfillment centers. Amazon Fresh stores are Amazon's physical supermarket format (distinct from Whole Foods) offering groceries alongside Amazon smart devices and Amazon-branded products at competitive pricing, deploying Amazon's Just Walk Out cashierless checkout and Dash Cart smart shopping cart technology in select locations.\n\nAmazon Fresh delivery integrates Prime membership — Prime members in select cities receive free same-day or next-day grocery delivery from Amazon Fresh and Whole Foods Market with no delivery fee on qualifying orders. The service competes with Instacart (multi-retailer delivery), Walmart Grocery, Target/Shipt, and local grocery delivery services for online grocery market share. Amazon's advantage is its same-day logistics infrastructure (Amazon Delivery Service Partners and Prime Air), Prime member loyalty, and Alexa integration for voice-activated grocery ordering.\n\nIn 2025, Amazon Fresh faces strategic recalibration — Amazon has slowed its Amazon Fresh physical store expansion and closed some locations while refining the format, indicating that the physical grocery concept requires further iteration before large-scale rollout. The Whole Foods acquisition (2017, $13.7 billion) remains Amazon's primary physical grocery presence. Amazon's grocery strategy faces competition from Walmart (which has significant grocery delivery scale through Walmart+) and Instacart (which powers delivery for many major grocery chains). The 2025 strategy focuses on optimizing the Amazon Fresh delivery economics, testing new store formats, and growing grocery share through Prime bundling.
FY2024 Sales: $88.8B (+4.3%) | Net Profit: $14.1B (+5.6%) | EPS: $5.79 | Adjusted EPS: $9.98 | FY2025 Guidance: Operational Sales Growth 2.5-3.5%, Adj EPS $10.75-$10.95 (+8.7% midpoint)
About
Johnson & Johnson is one of the world's largest healthcare companies, founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, where the company remains headquartered. Established to manufacture ready-to-use surgical dressings at a time when post-operative infection was a leading cause of surgical mortality, J&J was built on the scientific principles of antiseptic surgery advocated by Joseph Lister. The company trades on the NYSE under ticker JNJ and has evolved over 135+ years from a consumer health products manufacturer into a focused MedTech and pharmaceutical enterprise, completing the spinoff of its consumer health segment (Kenvue) in 2023.\n\nJohnson & Johnson now operates through two segments: Innovative Medicine and MedTech. Innovative Medicine encompasses oncology, immunology, neuroscience, infectious disease, and cardiovascular pharmaceutical products — including blockbusters Darzalex, Stelara, Tremfya, and Rybrevant. The MedTech segment includes surgical robotics (Ottava platform in development), electrophysiology (Abiomed, Biosense Webster), orthopedics (DePuy Synthes), and surgery systems, serving hospitals and surgical centers worldwide. Following the Kenvue separation, J&J is a pure-play healthcare technology and pharmaceutical company with significantly higher growth and margin profiles than its historical blended consumer-pharma-medtech structure.\n\nJohnson & Johnson reported FY2024 sales of $88.8 billion, up 4.3% year over year, with net profit of $14.1 billion, up 5.6%. The company's Innovative Medicine segment continues to grow driven by oncology and immunology portfolio strength, while MedTech benefits from procedure volume recovery and robotic surgery adoption. J&J's scale, R&D pipeline depth, and global commercial infrastructure — spanning more than 60 countries — position it as one of the two or three most consequential healthcare enterprises globally, with a patent portfolio, clinical trial network, and regulatory expertise that are nearly impossible to replicate.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.